Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pear Therapeutics, Inc.

Pear Therapeutics, Inc. (PEARW) Stock Overview

Explore Pear Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PEARW●NASDAQ
HealthcareMedical - Healthcare Information Services
$0.006
$0.00(0.00%)
U.S. Market opens in 63h 24m

Pear Therapeutics, Inc. (PEARW)

Meyka AI Score

Z

Key Financials

Market Cap4.1M
P/E Ratio-0.17
EPS (TTM)$-10.10
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PEARW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pear Therapeutics, Inc. (NASDAQ: PEARW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Pear Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PEARW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Pear Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.17 and a market capitalization of 4.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PEARW on the NASDAQ.

Price Performance (NASDAQ: PEARW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-94.64%
6-Month Change
-96.31%
Year-to-Date (YTD) Change
-95.09%
1-Year Change
-98.33%
3-Year Change
-99.41%
5-Year Change
-99.41%
All-Time (Max) Change
-99.41%

Contact Information

https://peartherapeutics.com
833 697 3738
200 State Street, Boston, MA, 02109

Company Facts

2,000 Employees
CountryUS

Frequently Asked Questions